SCHEMBL4002941

SCHEMBL4002941

Cc1c(C(N)=O)cccc1-c1cn(C)c(=O)c(Nc2ccc(N3CC[SH2]CC3=O)cc2)n1

nearest known ligand 0.44

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BTK Q06187 20/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16712281 0.85 BTK (0.44) BTK
SCHEMBL4001619 0.82 BTK (0.44) BTK
SCHEMBL3345984 0.81 BTK (0.49) BTK
SCHEMBL3346428 0.81 BTK (0.48) BTK
SCHEMBL3344333 0.81 BTK (0.47) BTK
SCHEMBL3347733 0.80 BTK (0.48) BTK
SCHEMBL3342944 0.80 BTK (0.47) BTK
SCHEMBL4002133 0.80 BTK (0.45) BTK
SCHEMBL3341831 0.80 BTK (0.46) BTK
SCHEMBL3346413 0.79 BTK (0.49) BTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2068849-A2 KINASE INHIBITORS, AND METHODS OF USING AND IDENTIFYING KINASE INHIBITORS CGI Pharmaceuticals, Inc. (US) 2009-06-17 EP disclosed
WO-2008033858-A2 KINASE INHIBITORS, AND METHODS OF USING AND IDENTIFYING KINASE INHIBITORS CGI PHARMACEUTICALS, INC. (US) 2008-03-20 WO disclosed